Jenny Doan, a 35-year-old Melbourne-based athlete and CEO, found her life dramatically altered when symptoms initially dismissed as burnout were diagnosed as multiple sclerosis (MS), a chronic neurological condition. Doan, who had built her identity around physical endurance and had been training for her fourth Guinness World Record – the most chin-ups completed while hula-hooping – began experiencing numbness in her feet in late 2024.
Initially, Doan attributed the sensations to her demanding schedule, which included a full-time job, motivational speaking, and rigorous training. She attempted to manage the symptoms through increased rest, reduced physical activity, and seeking answers through blood tests for nutrient deficiencies, but these yielded no conclusive results. "On paper, everything was normal, which was jarring, because I knew something was wrong," she stated.
As her symptoms progressed, Doan noticed instability when balancing and, more concerningly, numbness that spread to her hands with sudden weakness each time she performed chin-ups. This latter symptom prompted her general practitioner to suspect a spinal issue and order tests for autoimmune conditions, despite Doan's otherwise healthy appearance and normal blood work. Doan expressed gratitude for her doctor's attentiveness, noting that her physician did not dismiss her concerns as stress.
In January 2025, Doan was advised to go directly to the emergency department, where she was admitted to the stroke and brain injury ward pending an MRI. The diagnosis of MS, indicated by lesions on the scan consistent with the disease, came as a shock. Although she had encountered MS during online symptom searches, she had dismissed the possibility due to the initial vagueness of her symptoms.
Following the diagnosis, Doan underwent a five-day course of high-dose intravenous steroids to manage the immune response and inflammation. This was followed by a six-month infusion therapy called Ocrevus, which targets B cells implicated in the immune system's attack on the myelin sheath protecting nerve fibers. Subsequent imaging revealed no new or enlarged lesions, indicating the treatment was effectively controlling the disease.
The diagnosis has necessitated a significant adjustment to Doan's lifestyle. Fatigue, a pervasive symptom of MS, has impacted her ability to maintain her previous work and training intensity. She has restructured her daily life to incorporate planned rest periods, strategize task management, and conserve energy. Her professional role has shifted to a flexible CEO position at Shhit Happens, a toilet paper company supporting the disability community, allowing her to work around her health needs.
Doan has sought psychological support to navigate the emotional challenges of adapting to her condition and has found value in peer support from others living with MS. She emphasizes the importance of persistent medical advocacy for individuals experiencing prolonged or unexplained symptoms and highlights the critical role of affordable treatment access, such as through Australia's Pharmaceutical Benefits Scheme (PBS). The high cost of treatments like Ocrevus without subsidy ($33,000 annually) could create significant financial burdens and increased health uncertainty for patients.
Doan's perspective on strength has evolved from physical accomplishment to encompassing self-care, seeking help, and adapting to a future that differs from her initial expectations. "Strength now means resting before exhaustion, asking for help and allowing a team to carry responsibilities she once handled alone," she reflected. She continues to find purpose by adapting her life and goals to her current circumstances. 
